TcMedicine

Medicine and Health

Archive for June 26th, 2008

First New Oral Anticoagulant In More Than 40 Years Approved In Canada

Thursday, June 26th, 2008

Boehringer Ingelheim Canada Ltd. today announced that Health Canada has granted marketing authorization of PRADAX™ (dabigatran etexilate), a novel oral direct thrombin inhibitor (DTI) for the prevention of venous thromboembolism (VTE) in adult patients who have undergone elective total hip

New Data Demonstrates Joint Damage Is Inhibited With Wyeth

Thursday, June 26th, 2008

Study Results Provide Further Evidence That Early Treatment of Rheumatoid Arthritis With Enbrel(R) Plus Methotrexate in Moderate to Severe Patients can Stop the Disease From Progressing, and Helps Patients Return to More Normal and Productive Lives

Data presented today

GE Healthcare Clinical Systems Lunar Gets Top Ranking In Bone Mineral Densitometry Customer Satisfaction

Thursday, June 26th, 2008

In its latest report on bone mineral densitometry equipment, MD Buyline, an independent medical technology and informatics intelligence firm, has ranked GE Healthcare number one for the second consecutive quarter. Not only did GE Healthcare’s GE Lunar bone mineral densitometry products

Knee Pain Offered By Rush University Medical Center

Thursday, June 26th, 2008

Join orthopedic experts at Rush University Medical Center for a free informational discussion about advanced options in treating chronic knee pain. The free program will be held from 6 to 8:30 p.m., Tuesday, June 24 in Room 542 of the Searle Conference Center, located on the Rush campus, at 1725

U.S. Hispanic Women Face Osteoporosis

Thursday, June 26th, 2008

Osteoporosis is a disease that can be crippling, leaving bones brittle, weak and easily broken. There are already some 8 million women in the U.S. who suffer from osteoporosis* and experts say that number could soon skyrocket.

She may not quite understand the language yet, or the

FDA Broadens US Indication For Once-Yearly Reclast(R) As Only Osteoporosis Treatment Approved For Prevention Of Fractures After A Hip Fracture

Thursday, June 26th, 2008

The US Food and Drug Administration (FDA) has broadened the US indication for once-yearly Reclast® (zoledronic acid) Injection 5 mg[1] to include the prevention of new clinical fractures in patients who have recently had a low-trauma hip fracture1.

No other osteoporosis treatment has

Revision Of Osteoporosis Guidelines Led By Tufts Researcher

Thursday, June 26th, 2008

Tufts University researcher Bess Dawson-Hughes, M.D., chaired the committee that recently updated the National Osteoporosis Foundation (NOF) Clinician’s Guide to Prevention and Treatment of Osteoporosis. The new Clinician’s Guide incorporates the World Health Organization (WHO)

Alcohol Consumption Lowers Risk Of Rheumatoid Arthritis

Thursday, June 26th, 2008

Alcohol consumption has been linked with a decrease in risk ofdeveloping rheumatoid arthritis, according to an article released onJune 5, 2008 in the BMJ specialist journal Annals of theRheumatic Diseases.

Arthritis is a disease that involves damage to the joints of the

New Technology Could Help Prevent Fractures In Humans And Horses

Thursday, June 26th, 2008

Researchers are developing a monitoring system similar to those used by earthquake seismologists to detect tiny cracks in bones, a technology that could help prevent fractures in humans and racehorses.The new monitoring system records “acoustic emission data,” or sound waves created

Custom-Fit OtisKnee(TM) May Impact Early Success Of Total Knee Replacement Surgery, Study Finds

Thursday, June 26th, 2008

A new study from the University of Alabama at Birmingham indicates that the OtisKnee Custom Fit Knee™ Replacement system may have a positive impact on length of hospital stay, range of motion, pain level and patient satisfaction immediately following total knee replacement surgery. The